Clinical Trials Directory

Trials / Unknown

UnknownNCT02596633

A RCT of Telephone-supported ACT in MS

A Feasibility Randomized Control Trial (RCT) of Telephone-supported Acceptance and Commitment Therapy (ACT) for Low Mood in Multiple Sclerosis (MS)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will investigate the feasibility of running a randomised controlled trial (RCT) of a psychotherapy called "Acceptance and Commitment Therapy (ACT)", delivered in a self-help format with additional telephone support from a therapist, for people with Multiple Sclerosis (MS) and low mood.

Detailed description

A large proportion of people with Multiple Sclerosis (MS) suffer from emotional problems, therefore a large percentage of people with MS would be eligible to take part in a study offering a psychotherapeutic component to address these issues. Acceptance and Commitment Therapy (ACT) has been found to be effective for mood problems, and been successfully used in self-help format, but no study has thus-far examined potential for use as an effective intervention in this (MS) population. People will MS and low mood will be recruited from a neurology outpatient clinic. They will be randomized to either receive treatment as usual, or an ACT self-help book with 8 supportive telephone calls from a trainee clinical psychologist. Measures of anxiety, depression, quality of life and physical health will be administered at baseline, post-intervention and six month follow up. A sub sample of 10 participants will be interviewed to find out their view on taking part in the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelephone-support Acceptance and Commitment Therapy (ACT)Telephone-support Acceptance and Commitment Therapy (ACT): ACT self-help book and 8 telephone support calls

Timeline

Start date
2015-01-01
Primary completion
2016-03-01
Completion
2016-04-01
First posted
2015-11-04
Last updated
2016-02-18

Source: ClinicalTrials.gov record NCT02596633. Inclusion in this directory is not an endorsement.